🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 50 of 200 · A–Z by INN

  1. dasatinib (anhydrous)

    SPRYCEL

    EMA: approved

    L01EA02

  2. dasiglucagon

    ZEGALOGUE

    EMA: approved

    H04AA02

  3. dasiglucagon hydrochloride

    ZEGALOGUE

    SUBCUTANEOUS FDA: approved

  4. dasiprotimut-t

    LYMPREVA

    EMA: refused

    L03AX

  5. dato-dxd

    NMPA: clinical trials

  6. datopotamab deruxtecan

    DATOPOTAMAB DERUXTECAN DAIICHI SANKYO

    EMA: approved · PMDA: approved

    L01FX35

  7. datopotamab deruxtecan-dlnk

    DATROWAY

    IV (INFUSION) FDA: approved

  8. daunorubicin

    VYXEOS LIPOSOMAL (PREVIOUSLY VYXEOS) Jazz Pharmaceuticals Ireland Limited

    EMA: approved

    L01XY01

  9. daunorubicin + cytarabine

    VYXEOS Lacuna Pharma Pty Ltd

    TGA: approved

  10. daunorubicin citrate

    DAUNOXOME

    INJECTION FDA: approved

  11. daunorubicin hydrochloride

    DAUNORUBICIN HYDROCHLORIDE Teva Pharma GmbH

    INJECTION FDA: approved

  12. daxibotulinumtoxina-lanm

    DAXXIFY

    INTRAMUSCULAR, SUBCUTANEOUS FDA: approved

  13. decamethonium bromide

    SYNCURINE

    INJECTION FDA: approved

  14. decitabine

    DACOGEN

    INTRAVENOUS FDA: approved · EMA: approved · NMPA: clinical trials

    L01BC08

  15. decitabine + cedazuridine

    INQOVI 35/100 Lacuna Pharma Pty Ltd

    TGA: approved

  16. decoction

    NMPA: clinical trials

  17. defatted powder of arachis hypogaea l., semen (peanuts)

    PALFORZIA

    EMA: approved

    V01

  18. deferasirox

    DEFERASIROX JUNO Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    V03AC03

  19. deferiprone

    FERRIPROX Chiesi Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    V03AC02

  20. deferoxamine

    NMPA: clinical trials

  21. deferoxamine mesylate

    DEFEROXAMINE MESYLATE

    INJECTION FDA: approved

  22. defibrotide

    DEFITELIO

    EMA: approved

    B01AX01

  23. defibrotide sodium

    DEFITELIO Jazz Pharmaceuticals Ireland Limited

    INTRAVENOUS FDA: approved

  24. deflazacort

    DEFLAZACORT Amneal Pharma Europe Ltd

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources